BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, offering promising breakthroughs throughout numerous health-related and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA supplies a safer, much more reputable option for therapeutic